Primary myelofibrosis and its targeted therapy Lindsey ShantzerKristin BergerJeffrey J. Pu Review Article 19 August 2016 Pages: 531 - 535
Managing patients with myelofibrosis and low platelet counts Haifa Kathrin Al-AliAlessandro M. Vannucchi Review Article 21 May 2016 Pages: 537 - 548
Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion Massimo BrecciaPatrizia PregnoMichele Baccarani Review Article 30 September 2016 Pages: 549 - 558
Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy Jan K. HillerClaudia SchmoorBjörn Hackanson Original Article 05 January 2017 Pages: 559 - 565
Meis1 is critical to the maintenance of human acute myeloid leukemia cells independent of MLL rearrangements Jiangying LiuYa-Zhen QinXiao-Jun Huang Original Article 04 January 2017 Pages: 567 - 574
Second line azacitidine for elderly or infirmed patients with acute myeloid leukemia (AML) not eligible for allogeneic hematopoietic cell transplantation—a retrospective national multicenter study Ron RamMoshe GattYishai Ofran Original Article 05 January 2017 Pages: 575 - 579
Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection Miao ChenJunling ZhuangBing Han Original Article 13 January 2017 Pages: 581 - 587
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab Ferras AlashkarColin VanceAlexander Röth Original Article 26 January 2017 Pages: 589 - 596
Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients Ilham YoussryNohair SolimanAli Taher Original Article 07 February 2017 Pages: 597 - 603
Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience Shin Hye YooYoungil Kohfor the Korean Society of Blood and Marrow Transplantation Original Article 16 January 2017 Pages: 605 - 615
Nutritional risk in allogeneic stem cell transplantation: rationale for a tailored nutritional pathway Takashi AoyamaOsamu ImatakiTakashi Ikeda Original Article 03 January 2017 Pages: 617 - 625
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma Novella PuglieseM. Di PernaM. Picardi Original Article Open access 27 January 2017 Pages: 627 - 637
Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial Laura MagnanoSilvia MontotoArmando López-Guillermo Original Article 18 January 2017 Pages: 639 - 646
Low-dose pembrolizumab for relapsed/refractory Hodgkin lymphoma: high efficacy with minimal toxicity Thomas S. Y. ChanTsan-Hei LukYok-Lam Kwong Original Article 31 January 2017 Pages: 647 - 651
The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry Antoinetta J.M. BeijersSimone OerlemansLonneke V. van de Poll-Franse Original Article 23 January 2017 Pages: 653 - 663
Comprehensive assessment of peripheral blood TCRβ repertoire in infectious mononucleosis and chronic active EBV infection patients Shenglin LiuQian ZhangHongyu Zhang Original Article 14 January 2017 Pages: 665 - 680
Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate Christian ArrantoAlexandar TzankovJörg Halter Letter to the Editor 24 December 2016 Pages: 681 - 682
A treatment refractory CD30-positive diffuse large B cell lymphoma in the ileal neobladder Saeko OtaToshiki IwaiJunya Kuroda Letter to the Editor 28 December 2016 Pages: 683 - 684
Transient hypophysitis in a patient treated by duvelisib for chronic lymphocytic leukemia Laura OrioliK. SartiD. Maiter Letter to the Editor 01 February 2017 Pages: 685 - 686
Successful treatment of refractory Sezary syndrome by anti-PD-1 antibody (nivolumab) Kaini ShenYuehua LiuJian Li Letter to the Editor 24 January 2017 Pages: 687 - 688
Severe hepatitis B virus reactivation related to ibrutinib monotherapy Yair HerishanuHelena KatchmanAaron Polliack Letter to the Editor 05 January 2017 Pages: 689 - 690
Successful treatment with apixaban of sinus venous thrombosis due to pegylated asparaginase in a young adult with T cell acute lymphoblastic leukemia: case report and review of management Laura TalamoMichael DouvasDavid Ornan Letter to the Editor Open access 28 January 2017 Pages: 691 - 693
Rare myopathy associated to MGUS, causing heart failure and responding to chemotherapy Nicolas BelhommeAdel MaamarYves Le Tulzo Letter to the Editor 05 January 2017 Pages: 695 - 696
Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis Claudio CerchioneIlaria PelusoFabrizio Pane Letter to the Editor Open access 14 February 2017 Pages: 697 - 699
Vaccination of allogeneic hematopoietic stem cell transplant recipients—what should be considered? Inken HilgendorfHildegard GreinixDaniel Wolff Letter to the Editor 17 January 2017 Pages: 701 - 702
Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure Eva KnüppelMichael MedingerJakob Passweg Letter to the Editor 03 February 2017 Pages: 703 - 705
Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia Xueya ZhangJingxin Pan Letter to the Editor 02 February 2017 Pages: 707 - 708
Histoplasma capsulatum in a peripheral blood smear in a non-HIV patient Bhawna JhaSmeeta Gajendra Letter to the Editor 23 December 2016 Pages: 709 - 710
